Jennison Associates LLC Makes New Investment in Omada Health, Inc. $OMDA

Jennison Associates LLC purchased a new position in Omada Health, Inc. (NASDAQ:OMDA) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 250,250 shares of the company’s stock, valued at approximately $4,580,000. Jennison Associates LLC owned approximately 0.97% of Omada Health as of its most recent filing with the Securities and Exchange Commission.

Separately, Sanofi purchased a new stake in Omada Health in the 2nd quarter worth $9,606,000.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on OMDA. Baird R W upgraded Omada Health to a “hold” rating in a research report on Friday, September 5th. Evercore ISI set a $27.00 price target on Omada Health in a research note on Wednesday, October 8th. Barclays increased their price target on Omada Health from $24.00 to $28.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Weiss Ratings reissued a “sell (d)” rating on shares of Omada Health in a research note on Wednesday, October 8th. Finally, Needham & Company LLC increased their price target on Omada Health from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $25.50.

Omada Health Stock Up 1.3%

OMDA opened at $24.57 on Friday. Omada Health, Inc. has a 12 month low of $14.14 and a 12 month high of $28.40. The stock has a 50-day moving average of $23.64.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.07). The company had revenue of $61.37 million during the quarter, compared to the consensus estimate of $55.17 million. Omada Health has set its FY 2025 guidance at EPS.

Omada Health Profile

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.